WO1997007216A1 - Deuteriated substances - Google Patents

Deuteriated substances Download PDF

Info

Publication number
WO1997007216A1
WO1997007216A1 PCT/GB1996/001988 GB9601988W WO9707216A1 WO 1997007216 A1 WO1997007216 A1 WO 1997007216A1 GB 9601988 W GB9601988 W GB 9601988W WO 9707216 A1 WO9707216 A1 WO 9707216A1
Authority
WO
WIPO (PCT)
Prior art keywords
deuteriated
organism
substance
series
eftu
Prior art date
Application number
PCT/GB1996/001988
Other languages
French (fr)
Inventor
Jill Barber
Original Assignee
The Victoria University Of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Victoria University Of Manchester filed Critical The Victoria University Of Manchester
Priority to JP9509052A priority Critical patent/JPH11511023A/en
Priority to EP96927785A priority patent/EP0845038A1/en
Priority to AU67487/96A priority patent/AU721877B2/en
Publication of WO1997007216A1 publication Critical patent/WO1997007216A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells

Definitions

  • the present invention concerns methods for making substantially deuteriated substances and substances produced according to the method ofthe present invention.
  • Deuteriated proteins are normally obtained by growing E. coli bearing a suitable overproducing vector on a fully deuteriated medium.
  • the best medium used to date is deuteriated algal hydrolysate, but this is difficult to prepare, expensive and subject to fluctuations in availability (Daboll, H.F., et al, 1962, Biotechnology and Bioengineering, IV: 281).
  • the most widely used alternative is based on d 4 -succinate and D 2 0, but this medium is generally characterised by poor yields of protein (e.g. Oda, Y., et al, 1992, J. Biomol. NMR, 2: 137-147).
  • the present invention overcomes the disadvantages of the prior art and provides a simple, convenient, efficient, and less expensive method for producing substantially deuteriated substances.
  • a method for producing a substantially deuteriated substance comprising the steps of growing on a deuteriated medium an organism producing the substance, wherein the organism has been adapted to deuteriated medium such that on a deuteriated medium it produces approximately the same quantity of the deuteriated substance as the non-adapted organism produces ofthe non-deuteriated substance on a non-deuteriated medium.
  • the organism may be unicellular or multicellular.
  • the organism may, for example, be a bacterium, a prokaryote, an alga or a fungus.
  • the substance may for example be a protein, an antibiotic or nucleic acid.
  • the substance may be the bacterial elongation factor Tu (EFTu).
  • the substance produced may be at least 85% deuteriated. It may for example be at least 90% or 95% deuteriated.
  • the organism may have been adapted by growth in a series of cultures, the first culture containing less deuterium than the final culture.
  • the organism may have been grown to an A 550 of approximately 1.0 in each ofthe series of cultures.
  • Each culture in the series may contain more deuterium than the preceding culture.
  • the cultures may contain d 4 -succinate and D 2 0 as the sources of deuterium.
  • the series may be a series of at least three cultures. It may be a series of 3, 4, 5, 6, 7, 8, 9 or 10 cultures.
  • the organism may have been adapted by growth in a series of cultures containing d 4 -succinate and D 2 0, each culture ofthe series containing more deuterium than the preceding culture. It may for example have been a series of four cultures containing 70%, 80%, 90% and 100% D 2 0 respectively.
  • the organism may also have been further adapted to growth at a raised temperature. It may have been adapted to growth at 42°C.
  • 'raised temperature' is meant a raised temperature relative to the normal growth temperature for the organism, in the case of bacteria this being about 37°C.
  • the substance may be subsequently harvested.
  • the adapted organism may be E. coli or a derivative thereof. It may be derived from E. coli MRE600. It may for example be Bacillus subtilis or streptomyces, e.g. Saccharopolyspora erythraea. Derivatives of a micro-organism may be progeny of the micro-organism in which it has e.g. given up DNA to, or accepted DNA from, another micro-organism, the progeny exhibiting the same, or substantially the same, characteristics.
  • the adapted organism may be E. coli MRE600D.
  • the adapted organism may have been transformed. It may have been transformed with the pJBDB02 vector (also known as pTrc99AtufA, the tufA gene encoding EFTu).
  • the adapted organism may produce EFTu or a fragment, for example an immunogenic fragment, or a partially modified form thereof.
  • Partial modification may for example be by way of addition, deletion or substitution of amino acid residues.
  • a substitution may for example be a conserved substitution.
  • a partially modified molecule may be a homologue ofthe molecule from which it was derived. It may for example have at least 40%, for example 50, 60, 70, 80, 90 or 95% homology with the molecule from which it is derived.
  • the adapted organism may be E. coli MRE600DpJBDB02.
  • Also provided according to the present invention are substances produced according to the method ofthe present invention.
  • Bacterial elongation factor Tu is a 43 kDa protein which plays a crucial role in protein synthesis. It is the most extensively studied member of the G binding protein family, its role in bacteria being to deliver aminoacyl tRNA to the ribosome. EFTu binds a number of ligands including GTP, GDP, EFTs, aminoacyl tRNA, the ribosome, the antibiotics kirromycin and pulvomycin, and DNA. EFTu is too large for its interactions with these ligands to be studied satisfactorily with NMR using naturally abundant EFTu. However, deuteriated EFTu's interactions with these ligands may be readily studied, revealing hitherto unknown information about EFTu's interactions.
  • MRE600 or a derivative thereof for use in the production of a substantially deuteriated substance.
  • the MRE600 may be for use in a method according to any one ofthe preceding claims.
  • substantially deuteriated EFTu having a substantially longer half-life in protiated media in the presence of chymotrypsin than protiated EFTu.
  • substantially deuteriated EFTu has been prepared, allowing it to be studied with NMR.
  • Figure 1 shows plasmid pJBDB02.
  • Bases 1512-270 (the tufA EcoRI restriction site to the Smal restriction site) are derived from pTrc99A and the J226 bp tufA fragment was isolated from pJBDBOl by EcoRI digestion;
  • Figure 2 shows SDS PAGE of crude cell lysate from MRE600DpJBDB02 cells grown on deuteriated succinate medium.
  • Lanes 1 and 6 contain molecular weight markers of 14, 20, 30, 43, 67 and 94 kDa.
  • Lane 2 contains a sample of crude cell lysate from a non- induced culture;
  • lane 3 contains a sample of crude cell lysate from am IPTG-induced culture;
  • lanes 4 and 5 contain 1 :10 dilutions of the lysate samples loaded into lanes 2 and 3 respectively.
  • the strong band of EFTu at 43 kDa is clearly visible in samples from the induced culture and the high yield of EFTu in relation to other cell proteins is demonstrated;
  • Figure 3 shows the degradation of perdeuteriated and protiated EFTu at 42 °C in H 2 0 (pH 8.0) and D 2 0 (pD 8.0);
  • Figure 4 shows the degradation of perdeuteriated and protiated EFTu at 51 °C in D 2 0 (pD 8.0);
  • Figure 5 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in protiated media
  • Figure 6 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in deuteriated media.
  • Bacteria were adapted to growth on deuteriated succinate medium and were transformed with a plasmid DNA vector. Resultant clones were screened for the presence ofthe vector and their ability to synthesise deuteriated EFTu.
  • Results show that the method of the present invention has allowed the preparation of very high yields (nearly 100 mg/litre of culture medium) of deuteriated EFTu using a series of cultures containing d 4 -succinate/D 2 0 medium.
  • the yields are equal to those obtained using natural abundance medium and the same clone.
  • Deuteriated sodium succinate was prepared essentially as described by Stella, V.J., et al. (1973, J. Pharm. Sci., 62: 634) and LeMaster, D.M. and Richards, F.M. (1981, Analytical Biochemistry, 122: 238-247).
  • Deuteriated sodium succinate medium was prepared as follows: 0.1 g NaOH, 2.4 g KH 2 P0 4 , 1.1 g deuteriated sodium succinate, 0.2 g (NH 4 ) 2 S0 4 , 30 mg FeS0 4 , 1 ⁇ l cone.
  • H 2 S0 4 (Fissons) were slurried in 1 ml of 2 H 2 0 (D 2 0; Fluorochem) and stirred for 1 hour. The mixture was freeze dried and resuspended in 100 ml of 2 H 2 0 and filter sterilised.
  • bacto agar For preparation of agar plates, 1.5 g bacto agar were added to 100 ml medium which was sterilised by autoclaving at 15 lb/sq.inch (approx. 10546 kg/ ⁇ r)for 20 minutes at 121 °C, in a sealed Duran bottle.
  • E. C0/ MRE6OO National Collection of Industrial and Marine Bacteria
  • was adapted to growth on deuteriated medium by growing successive liquid cultures in medium containing deuteriated sodium succinate as a carbon source in 70%, 80%, 90% and, finally, 100% 2 H 2 0.
  • MRE600 adapted in this way are denoted MRE600D.
  • the fragment was isolated from a low melting point agarose gel (BRL;
  • E. coli MRE600D cells grown for a single generation on Luria's broth (LB) medium were made competent by treatment with calcium chloride and were transformed according to the method of Mandel, M. and Higa, A. (1970, J. Mol. Biol., 53_: 154-162). 10 ⁇ l of ligation products containing 100 ng of Trc99A DNA were added to 200 ⁇ l of competent cells and the suspension was incubated on ice for 1-3 hours before heat shocking at 42 °C for 2 minutes.
  • LB medium was used in the transformation procedure, and transformants were placed on LB agar plates supplemented with 100 ⁇ g/ml ampicillin (Sigma). Following incubation overnight at 37°C, colonies were replica plated onto deuteriated succinate agar plates. Screening of MRE600DpJBDB02 clones
  • the culture was grown at 37°C with shaking 250 rpm ( 3 /4 inch (1.9 cm) stroke). After approximately 40 hours incubation, when the optical density measured at 550 nm (OD 550 ) ofthe culture had reached 0.4, the culture was divided between two sterile 250 ml flasks. One ofthe cultures was induced by the addition of isopropylthiogalactoside (IPTG; NovaBiochem) to a final concentration of 1 mM, and incubation of both was continued as described. After a further 24 and 48 hours growth, two 1 ml samples were taken from each flask r and the cells isolated and lysed as described previously (Bloor and Barber, 1993, supra).
  • IPTG isopropylthiogalactoside
  • E. coli MRE600 which had not undergone adaptation to deuteriation could not be cultured in deuteriated medium.
  • E. coli MRE600 which had undergone adaptation achieved a maximum OD 550 of 6.0 and cultures had a doubling time of approximately 6 hours.
  • Plating deuterium adapted bacteria on deuteriated agar plates proved to be particularly important, resulting in improved growth rates and much reduced variability between cultures.
  • Competent cells prepared from MRE600D cells grown for a single generation on protiated LB medium were successfully transformed with plasmid pBR322 when large quantities (100 ng) of DNA were used.
  • MRE600D cells were also successfully transformed with plasmid pJBDB02 and, following transformation, it was possible to isolate transformants which had retained their ability to grow on deuteriated medium from replica deuteriated succinate agar plates. The feasibility of storing bacteria grown on deuteriated medium as frozen glycerol stocks has also been demonstrated.
  • the yield of EFTu from deuteriated cultures ofthe MRE600DpJBDB02 clone was more than four times higher than that obtained from deuteriated cultures of MRE600pCP40pCI857 (Howard, T.D., 1991, PhD Thesis. University of Manchester, UK; Kennedy, K.K.. 1992, PhD Thesis, University of Manchester, UK).
  • solutions of protiated or perdeuteriated EFTu were prepared at 0.5-0.6 mg ml "1 in 64.4 mM Tris buffer, pH 8 in H 2 0 or pD 8 in D 2 0.
  • Samples of each ofthe four solutions protiated EFTu in H 2 O and D 2 0, perdeuteriated EFTu in H 2 0 and D 2 0 were allowed to denature at 8 °C, room temperature at 42 C C ( Figure 4).
  • Protiated and perdeuteriated EFTu in D 2 0 were also degraded at 51 °C. All experiments were carried out in duplicate. Samples were removed at intervals and assayed for EFTu by the standard GDP exchange assay.
  • D 2 0 has a stabilizing effect on both protiated and perdeuteriated EFTu at all the temperatures measured. For example at 42 °C the half life of normal EFTu is 70 minutes in H 2 O but 350 minutes in D 2 0. D 2 0 is known to affect the stability of proteins in aqueous solution. In many cases the effect is stabilizing, but destabilizing effects have also been reported.
  • EFTu is an unstable protein which associates readily and which is stabilized in concentration solution. The destabilization of EFTu on perdeuteriation appears to arise from changes in hydrophobic interactions, including a decrease in association behaviour.
  • t /2 represents the time after which one half of the protein has degraded. This is a true half life only at elevated temperatures.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a method for producing a substantially deuteriated substance comprising the steps of growing on a deuteriated medium an organism producing the substance, wherein the organism has been adapted to deuteriated medium such that on a deuteriated medium it produces approximately the same quantity of the deuteriated substance as the non-adapted organism produces of the non-deuteriated substance on a non-deuteriated medium. Also provided are substances produced according to the method of the present invention, MRE600 for use in a method of production of a substantially deuteriated substance, and substantially deuteriated EFTu having a substantially greater half-life in the presence of chymotrypsin in protiated media than protiated EFTu.

Description

DEUTERTATED SUBSTANCES
The present invention concerns methods for making substantially deuteriated substances and substances produced according to the method ofthe present invention.
Fully deuteriated proteins are being used increasingly in both NMR (Nuclear Magnetic Resonance) and neutron scattering experiments. Deuteriation increases the resolution obtainable in neutron scattering, and allows proteins under study (deuteriated) to be distinguished from background (natural abundance) (Moore, P., 1979, Methods in Enzymology, 59: 639-655). In Η NMR studies of ligand-protein interactions, the protein can be rendered transparent by deuteriation (Seeholzer, S.H., et al., 1986, Proc. Natl. Acad. Sci. USA., 83: 3634). 'H-'H dipole-dipole interactions are reduced resulting in relatively narrow signals in one- and multi-dimensional spectra, and the quality of NOES Y spectra is further improved by the reduction in spin diffusion effects (Brennan, R.J., et al, 1994, J. Chem. Soc. Chem. Commun., 1615).
Deuteriated proteins are normally obtained by growing E. coli bearing a suitable overproducing vector on a fully deuteriated medium. The best medium used to date is deuteriated algal hydrolysate, but this is difficult to prepare, expensive and subject to fluctuations in availability (Daboll, H.F., et al, 1962, Biotechnology and Bioengineering, IV: 281). The most widely used alternative is based on d4-succinate and D20, but this medium is generally characterised by poor yields of protein (e.g. Oda, Y., et al, 1992, J. Biomol. NMR, 2: 137-147). Good yields of deuteriated chloramphenicol acetyltransferase have been obtained using d4-succinate medium, but even these were a factor of four lower than yields of natural abundance protein prepared using the same clone (Derrick. J.P., et al, 1992. Biochemistry, 31: 8191-8195). The present invention overcomes the disadvantages of the prior art and provides a simple, convenient, efficient, and less expensive method for producing substantially deuteriated substances.
According to the present invention there is provided a method for producing a substantially deuteriated substance comprising the steps of growing on a deuteriated medium an organism producing the substance, wherein the organism has been adapted to deuteriated medium such that on a deuteriated medium it produces approximately the same quantity of the deuteriated substance as the non-adapted organism produces ofthe non-deuteriated substance on a non-deuteriated medium.
The organism may be unicellular or multicellular. The organism may, for example, be a bacterium, a prokaryote, an alga or a fungus.
The substance may for example be a protein, an antibiotic or nucleic acid. The substance may be the bacterial elongation factor Tu (EFTu).
The substance produced may be at least 85% deuteriated. It may for example be at least 90% or 95% deuteriated.
The organism may have been adapted by growth in a series of cultures, the first culture containing less deuterium than the final culture.
The organism may have been grown to an A550 of approximately 1.0 in each ofthe series of cultures.
Each culture in the series may contain more deuterium than the preceding culture. The cultures may contain d4-succinate and D20 as the sources of deuterium.
The series may be a series of at least three cultures. It may be a series of 3, 4, 5, 6, 7, 8, 9 or 10 cultures.
The organism may have been adapted by growth in a series of cultures containing d4-succinate and D20, each culture ofthe series containing more deuterium than the preceding culture. It may for example have been a series of four cultures containing 70%, 80%, 90% and 100% D20 respectively.
The organism may also have been further adapted to growth at a raised temperature. It may have been adapted to growth at 42°C. By 'raised temperature' is meant a raised temperature relative to the normal growth temperature for the organism, in the case of bacteria this being about 37°C.
The substance may be subsequently harvested.
The adapted organism may be E. coli or a derivative thereof. It may be derived from E. coli MRE600. It may for example be Bacillus subtilis or streptomyces, e.g. Saccharopolyspora erythraea. Derivatives of a micro-organism may be progeny of the micro-organism in which it has e.g. given up DNA to, or accepted DNA from, another micro-organism, the progeny exhibiting the same, or substantially the same, characteristics.
The adapted organism may be E. coli MRE600D. The adapted organism may have been transformed. It may have been transformed with the pJBDB02 vector (also known as pTrc99AtufA, the tufA gene encoding EFTu).
The adapted organism may produce EFTu or a fragment, for example an immunogenic fragment, or a partially modified form thereof. Partial modification may for example be by way of addition, deletion or substitution of amino acid residues. A substitution may for example be a conserved substitution. Hence a partially modified molecule may be a homologue ofthe molecule from which it was derived. It may for example have at least 40%, for example 50, 60, 70, 80, 90 or 95% homology with the molecule from which it is derived.
The adapted organism may be E. coli MRE600DpJBDB02.
Also provided according to the present invention are substances produced according to the method ofthe present invention.
Bacterial elongation factor Tu is a 43 kDa protein which plays a crucial role in protein synthesis. It is the most extensively studied member of the G binding protein family, its role in bacteria being to deliver aminoacyl tRNA to the ribosome. EFTu binds a number of ligands including GTP, GDP, EFTs, aminoacyl tRNA, the ribosome, the antibiotics kirromycin and pulvomycin, and DNA. EFTu is too large for its interactions with these ligands to be studied satisfactorily with NMR using naturally abundant EFTu. However, deuteriated EFTu's interactions with these ligands may be readily studied, revealing hitherto unknown information about EFTu's interactions.
According to the present invention there is also provided MRE600 or a derivative thereof for use in the production of a substantially deuteriated substance. The MRE600 may be for use in a method according to any one ofthe preceding claims. Also provided according to the present invention is substantially deuteriated EFTu having a substantially longer half-life in protiated media in the presence of chymotrypsin than protiated EFTu.
Using the method of the present invention (see 'Experimental' section below), substantially deuteriated EFTu has been prepared, allowing it to be studied with NMR.
The invention will be further apparent from the following description which shows, by way of example only, one form of method of producing substantially deuteriated substances. Ofthe figures:
Figure 1 shows plasmid pJBDB02. Bases 1512-270 (the tufA EcoRI restriction site to the Smal restriction site) are derived from pTrc99A and the J226 bp tufA fragment was isolated from pJBDBOl by EcoRI digestion;
Figure 2 shows SDS PAGE of crude cell lysate from MRE600DpJBDB02 cells grown on deuteriated succinate medium. Lanes 1 and 6 contain molecular weight markers of 14, 20, 30, 43, 67 and 94 kDa. Lane 2 contains a sample of crude cell lysate from a non- induced culture; lane 3 contains a sample of crude cell lysate from am IPTG-induced culture; lanes 4 and 5 contain 1 :10 dilutions of the lysate samples loaded into lanes 2 and 3 respectively. The strong band of EFTu at 43 kDa is clearly visible in samples from the induced culture and the high yield of EFTu in relation to other cell proteins is demonstrated;
Figure 3 shows the degradation of perdeuteriated and protiated EFTu at 42 °C in H20 (pH 8.0) and D20 (pD 8.0); Figure 4 shows the degradation of perdeuteriated and protiated EFTu at 51 °C in D20 (pD 8.0);
Figure 5 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in protiated media; and
Figure 6 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in deuteriated media.
EXPERIMENTAL
Bacteria were adapted to growth on deuteriated succinate medium and were transformed with a plasmid DNA vector. Resultant clones were screened for the presence ofthe vector and their ability to synthesise deuteriated EFTu.
Results show that the method of the present invention has allowed the preparation of very high yields (nearly 100 mg/litre of culture medium) of deuteriated EFTu using a series of cultures containing d4-succinate/D20 medium. The yields are equal to those obtained using natural abundance medium and the same clone. These results compare extremely well with the prior art results which showed a four-fold reduction in protein production levels when bacteria were cultured on deuteriated medium (Derrick et al, 1992).
Synthesis of deuteriated sodium succinate
Deuteriated sodium succinate was prepared essentially as described by Stella, V.J., et al. (1973, J. Pharm. Sci., 62: 634) and LeMaster, D.M. and Richards, F.M. (1981, Analytical Biochemistry, 122: 238-247).
Adaptation ofMRE600 to growth on deuteriated succinate medium Deuteriated sodium succinate medium was prepared as follows: 0.1 g NaOH, 2.4 g KH2P04, 1.1 g deuteriated sodium succinate, 0.2 g (NH4)2S04, 30 mg FeS04, 1 μl cone. H2S04 (Fissons) were slurried in 1 ml of 2H20 (D20; Fluorochem) and stirred for 1 hour. The mixture was freeze dried and resuspended in 100 ml of 2H20 and filter sterilised. For preparation of agar plates, 1.5 g bacto agar were added to 100 ml medium which was sterilised by autoclaving at 15 lb/sq.inch (approx. 10546 kg/πr)for 20 minutes at 121 °C, in a sealed Duran bottle. E. C0/ MRE6OO (National Collection of Industrial and Marine Bacteria) was adapted to growth on deuteriated medium by growing successive liquid cultures in medium containing deuteriated sodium succinate as a carbon source in 70%, 80%, 90% and, finally, 100% 2H20. The cells were then plated on 100% 2H20 deuteriated succinate agar plates and incubated for 48 hours at 37°C at which time a single colony was selected and grown in liquid culture until stationary phase was reached. Glycerol stocks were made from the culture, and the adapted cells were stored at -20 °C for periods of up to 1 year. MRE600 adapted in this way are denoted MRE600D.
Construction ofthepJBD02 vector
A 1226 bp fragment encoding the tufA was excised from pJBDBOl (Bloor, D.J. and
Barber, J., 1993, Biochemistry and Molecular Biology International, 31(4): 727-731) by
EcoRI digestion. The fragment was isolated from a low melting point agarose gel (BRL;
Ultrapure RTM) using Geneclean (Stratech; RTM), and ligated into the EcoRJ site of pTrc99A. The ligation products were used to transform competent MRE600D cells (see below).
Transformation ofMRE600D with Plasmid DNA
E. coli MRE600D cells grown for a single generation on Luria's broth (LB) medium were made competent by treatment with calcium chloride and were transformed according to the method of Mandel, M. and Higa, A. (1970, J. Mol. Biol., 53_: 154-162). 10 μl of ligation products containing 100 ng of Trc99A DNA were added to 200 μl of competent cells and the suspension was incubated on ice for 1-3 hours before heat shocking at 42 °C for 2 minutes. LB medium was used in the transformation procedure, and transformants were placed on LB agar plates supplemented with 100 μg/ml ampicillin (Sigma). Following incubation overnight at 37°C, colonies were replica plated onto deuteriated succinate agar plates. Screening of MRE600DpJBDB02 clones
10 transformants were grown in LB medium and small scale plasmid isolations were carried out using the Promega Magic Miniprep (RTM) system. Plasmids were screened by Smal digestion and agarose gel electrophoresis, and plasmids shown to contain the tufA gene in the correct orientation with respect to the trc promoter of pTRC99A were denoted pJBDB02 (see Figure 1). A single MRE600DρJBDB02 clone was then picked from the deuteriated succinate replica plate and used to inoculate 40 ml of deuteriated succinate medium containing 100 μg/ml ampicillin. The culture was grown at 37°C with shaking 250 rpm (3/4 inch (1.9 cm) stroke). After approximately 40 hours incubation, when the optical density measured at 550 nm (OD550) ofthe culture had reached 0.4, the culture was divided between two sterile 250 ml flasks. One ofthe cultures was induced by the addition of isopropylthiogalactoside (IPTG; NovaBiochem) to a final concentration of 1 mM, and incubation of both was continued as described. After a further 24 and 48 hours growth, two 1 ml samples were taken from each flaskr and the cells isolated and lysed as described previously (Bloor and Barber, 1993, supra). Measurement of EFTu levels in the crude cell lysates was carried out using the GDP exchange assay described previously by Arai, K. et al (1980, Proc. Natl. Acad. Sci. USA., 77(3): 1326-1330). SDS PAGE was also used to evaluate EFTu expression by both the induced and non-induced cultures (Pharmacia Phastgel System), and total cell protein in crude cell lysates was estimated using the Bradford Assay (Bradford, M.M., 1976, Analytical Biochemistry, 72: 248-254).
RESULTS AND DISCUSSION
E. coli MRE600 which had not undergone adaptation to deuteriation could not be cultured in deuteriated medium. E. coli MRE600 which had undergone adaptation achieved a maximum OD550 of 6.0 and cultures had a doubling time of approximately 6 hours. Plating deuterium adapted bacteria on deuteriated agar plates proved to be particularly important, resulting in improved growth rates and much reduced variability between cultures.
Competent cells prepared from MRE600D cells grown for a single generation on protiated LB medium were successfully transformed with plasmid pBR322 when large quantities (100 ng) of DNA were used. Using the same procedure, MRE600D cells were also successfully transformed with plasmid pJBDB02 and, following transformation, it was possible to isolate transformants which had retained their ability to grow on deuteriated medium from replica deuteriated succinate agar plates. The feasibility of storing bacteria grown on deuteriated medium as frozen glycerol stocks has also been demonstrated.
Measurement of EFTu levels in crude lysates of MRE600DpJBDB02 grown on deuteriated medium showed that the IPTG-induced culture produced an excellent 100 mg of labelled EFTu per litre of cell culture. Non-induced culture of MRE600DpJBDB02 cells produced only 12 mg of EFTu per litre of culture. Figure 2 shows the result of SDS PAGE of a samples crude lysate obtained from induced and non- induced MRE60DpJBDB02 cells grown on deuteriated media.
The yield of EFTu from deuteriated cultures ofthe MRE600DpJBDB02 clone was more than four times higher than that obtained from deuteriated cultures of MRE600pCP40pCI857 (Howard, T.D., 1991, PhD Thesis. University of Manchester, UK; Kennedy, K.K.. 1992, PhD Thesis, University of Manchester, UK). Expression of tufA in the MRE600pCP40pCI857 clone (which had previously been the best overproducer of deuteriated EFTu available), is under the influence of a λPL promoter, but there is some evidence to suggest that the EcoRl/Hindlll fragment encoding tufA in pCP40 also encodes regulatory sequences which may influence expression ofthe gene under conditions of poor growth (van der Meide, R.A. et al, 1983, European Journal of Biochemistry, 130: 409-417).
Additional EFTu was isolated using the method of Wittinghoefer, A. and Leberman, R., 1976, Eur. J. Biochem., 62: 373-382. Electrospray mass spectrometry of the perdeuteriated protein gave a molecular ion of 45574 which fell to 45527 on 12 hours incubation under mildly denaturing conditions (20% H20, 1% HCOOH in CH3CN). Under the same conditions, with D20 replacing H20, the molecular weight ofthe normal protiated protein rose from 43219 to 43860 corresponding to the exchange of 637 hydrogens. The EFTu molecule contains 668 hydrogens linked to heteroatoms, so these data indicate that about 30 of these do not exchange under these conditions. Taking this into account, these results indicate that the deuteriated protein was 95% deuteriated at the CD positions, and that about 78 (12%) of the deuteriums attached to heteroatoms survived the long (8 hours) work up in H20.
Additionally, solutions of protiated or perdeuteriated EFTu were prepared at 0.5-0.6 mg ml"1 in 64.4 mM Tris buffer, pH 8 in H20 or pD 8 in D20. Samples of each ofthe four solutions (protiated EFTu in H2O and D20, perdeuteriated EFTu in H20 and D20 were allowed to denature at 8 °C, room temperature at 42 CC (Figure 4). Protiated and perdeuteriated EFTu in D20 were also degraded at 51 °C. All experiments were carried out in duplicate. Samples were removed at intervals and assayed for EFTu by the standard GDP exchange assay.
It is clear from the results (Figures 3 and 4; Table 1) that D20 has a stabilizing effect on both protiated and perdeuteriated EFTu at all the temperatures measured. For example at 42 °C the half life of normal EFTu is 70 minutes in H2O but 350 minutes in D20. D20 is known to affect the stability of proteins in aqueous solution. In many cases the effect is stabilizing, but destabilizing effects have also been reported.
The denaturation of EFTu followed complex kinetics, approaching a normal exponential decay only at elevated temperature (42 °C for H20 solutions, 51 °C for D20 solutions). At elevated temperatures the errors are negligible whereas the slow initial phase of degradation seen at lower temperatures varies slightly in duration (see Table 1). It can be seen, however, that perdeuteriation ofthe protein is under almost all conditions stabilizing.
The residual heteroatom deuteriums, which are presumably buried in the core ofthe protein, are expected to be stabilizing as deuterium bonds are stronger than hydrogen bonds. The destabilizing effect therefore presumably derives from the.carbon- bound deuteriums (of which there are 2399). EFTu is an unstable protein which associates readily and which is stabilized in concentration solution. The destabilization of EFTu on perdeuteriation appears to arise from changes in hydrophobic interactions, including a decrease in association behaviour.
Experiments have also shown (Figures 5 and 6) that perdeuteriated EFTu has a significantly longer half-life (60 minutes compared to 40 minutes) in the presence of chymotrypsin than protiated EFTu in protiated media. TABLE 1
Half-lives of protiated and perdeuteriated EFTu in H20 and D20 at various temperatures
Temperature (°C)
8 19 42 52
Protiated EFTu in H20 t, (mins) a 1400±100 67.5±12.5 -
Protiated EFTu in D20 tΛ (mins) a >3300 350±30 30±1
Deuteriated EFTu in H20 t.Λ (mins) a 1750±50 70±2 -
Deuteriated EFTu in D20 t,Λ (mins) a >2000 225±25 lO±l
a - does not degrade appreciably after 55 hours
t/2 represents the time after which one half of the protein has degraded. This is a true half life only at elevated temperatures.

Claims

1. A method for producing a substantially deuteriated substance comprising the steps of growing on a deuteriated medium an organism producing the substance, wherein the organism has been adapted to deuteriated medium such that on a deuteriated medium it produces approximately the same quantity ofthe deuteriated substance as the non-adapted organism produces ofthe non-deuteriated substance on a non-deuteriated medium.
2. A method according to claim 1 wherein the organism is unicellular.
3. A method according to claim 1 wherein the organism is multicellular.
4. A method according to any one of claims 1-3 wherein the organism is selected from any one ofthe group of classes of bacterium, prokaryote, alga and fungus.
5. A method according to claim 1 wherein the substance is either a protein or an antibiotic.
6. A method according to claim 5 wherein the substance is the bacterial elongation factor Tu.
7. A method according to any one of the preceding claims wherein the substance produced is at least 85% deuteriated.
8. A method according to claim 7 wherein the substance produced is at least 90% deuteriated.
9. A method according to claim 8 wherein the substance produced is at least 95% deuteriated.
10. A method according to any one of the preceding claims wherein the organism has been adapted by growth in a series of cultures, the first culture containing less deuterium than the final culture.
11. A method according to claim 10 wherein the organism has been grown to an A550 of approximately 1.0 in each ofthe series of cultures.
12. A method according to either one of claims 10 or 11 wherein each culture contains more deuterium than the preceding culture.
13. A method according to any one of claims 10-12 wherein the .cultures contain d4-succinate and D20.
14. A method according to any one of claims 10-13 wherein the series is a series of at least three cultures.
15. A method according to claim 14 wherein the series is a series selected from any one ofthe group of 3, 4, 5, 6, 7, 8, 9, and 10 cultures.
16. A method according to any one of claims 10-15 wherein the organism has been adapted by growth in a series of cultures containing d4-succinate and D20, each culture ofthe series containing more deuterium than the preceding culture.
17. A method according to claim 16 wherein it is a series of four cultures containing 70%, 80%, 90% and 100% D20 respectively.
18. A method according to any one of the preceding claims wherein the organism is further adapted to growth at a raised temperature.
19. A method according to claim 18 wherein the organism is adapted to growth at 42° C.
20. A method according to any one of the preceding claims wherein the substance is subsequently harvested.
21. A method according to any one of the preceding claims wherein the adapted organism is E. coli or a derivative thereof.
22. A method according to claim 21 wherein the adapted organism is derived from£. cø// MRE600.
23. A method according to claim 22 wherein the adapted organism is E. coli MRE600D.
24. A method according to any one of the preceding claims wherein the adapted organism has been transformed.
25. A method according to claim 21 wherein the adapted organism has been transformed with the pJBDB02 vector.
26. A method according to any one of claims 18-22 wherein the adapted organism produces EFTu or a fragment thereof.
27. A method according to any one of claims 18-23 wherein the adapted organism is E. coli MRE600DpJBDB02.
28. A substance produced according to the method of any one ofthe preceding claims.
29. MRE600 for use in a method of production of a substantially deuteriated substance.
30. MRE600 according to claim 29 for use in a method according to any one of claims 1-27.
31. Substantially deuteriated EFTu having a substantially greater half-life in the presence of chymotrypsin in protiated media than protiated EFTu.
PCT/GB1996/001988 1995-08-19 1996-08-14 Deuteriated substances WO1997007216A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP9509052A JPH11511023A (en) 1995-08-19 1996-08-14 Deuterated substance
EP96927785A EP0845038A1 (en) 1995-08-19 1996-08-14 Deuteriated substances
AU67487/96A AU721877B2 (en) 1995-08-19 1996-08-14 Deuteriated substances

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9517026.2 1995-08-19
GB9517026A GB2304343A (en) 1995-08-19 1995-08-19 Deuterated product from culture in a deuterated medium

Publications (1)

Publication Number Publication Date
WO1997007216A1 true WO1997007216A1 (en) 1997-02-27

Family

ID=10779491

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/001988 WO1997007216A1 (en) 1995-08-19 1996-08-14 Deuteriated substances

Country Status (6)

Country Link
EP (1) EP0845038A1 (en)
JP (1) JPH11511023A (en)
AU (1) AU721877B2 (en)
CA (1) CA2230051A1 (en)
GB (1) GB2304343A (en)
WO (1) WO1997007216A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012048A2 (en) * 2001-07-31 2003-02-13 Board Of Regents, University Of Texas System Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
WO2014078014A2 (en) 2012-11-14 2014-05-22 Metabolix, Inc. Production of salts of 4-hydroxybutyrate using biobased raw materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206691A2 (en) * 1985-06-17 1986-12-30 Nippon Paint Co., Ltd. Production of deuterium-containing chemical substances

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05246938A (en) * 1992-02-19 1993-09-24 Sagami Chem Res Center Heavy hydrogen labeled higher fatty acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206691A2 (en) * 1985-06-17 1986-12-30 Nippon Paint Co., Ltd. Production of deuterium-containing chemical substances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KALBITZER H.R. ET AL.: "1H-NMR spectroscopy on elongation factor Tu from Escherichia coli", FEBS LETTERS, vol. 180, no. 1, 21 January 1985 (1985-01-21), pages 40 - 42, XP000611950 *
KENNEDY K. ET AL.: "The molecular basis of the interaction of EF-Tu with kirromycin: overproduction of perdeuterated EF-Tu", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 19, no. 3, August 1991 (1991-08-01), pages 284s, XP000611936 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012048A2 (en) * 2001-07-31 2003-02-13 Board Of Regents, University Of Texas System Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
WO2003012048A3 (en) * 2001-07-31 2004-01-15 Univ Texas Antigens of and antibodies to translocated molecules of microorganisms and uses thereof
WO2014078014A2 (en) 2012-11-14 2014-05-22 Metabolix, Inc. Production of salts of 4-hydroxybutyrate using biobased raw materials
US11111202B2 (en) 2012-11-14 2021-09-07 Cj Cheiljedang Corporation Production of salts of 4-hydroxybutyrate using biobased raw materials

Also Published As

Publication number Publication date
AU6748796A (en) 1997-03-12
GB2304343A (en) 1997-03-19
CA2230051A1 (en) 1997-02-27
JPH11511023A (en) 1999-09-28
AU721877B2 (en) 2000-07-13
GB9517026D0 (en) 1995-10-25
EP0845038A1 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
Saint-Girons et al. Methionine biosynthesis in enterobacteriaceae: Biochemical, regulatory, and evolutionary aspect
US7785832B2 (en) Method of protein synthesis
FR2627508A1 (en) METHOD FOR THE INTEGRATION OF A GENE CHOOSED ON CHROMOSOME OF A BACTERIUM AND BACTERIUM OBTAINED BY SAID METHOD
JPS6038114B2 (en) Method for producing gene products from plasmid DNA
US8241887B2 (en) High density growth of T7 expression strains with auto-induction option
CA2968491C (en) Codon optimized polynucleotide for high level expression of crm197
EP1412504B1 (en) Methods of rna and protein synthesis
Hill et al. Overexpression, purification, and characterization of Escherichia coli acyl carrier protein and 2 mutant proteins
CA2183632A1 (en) Process for producing 2-keto-l-gulonic acid
AU721877B2 (en) Deuteriated substances
US5786192A (en) Farnesyl pyrophosphate synthetase and DNA sequence encoding the same
EP0233019A2 (en) Recombinant DNA plasmid for xanthan gum synthesis
US4393135A (en) Method for producing L-glutamic acid by fermentation
EP0469919A2 (en) A process for the enzymatic preparation of 7-aminocephalosporanic acid
WO2004053111A1 (en) Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same
EP0513806B1 (en) Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said transformants
US4504581A (en) Method for producing L-histidine by fermentation
BRPI0719263A2 (en) BETA-LACTAMA ANTIBIOTIC PRODUCTION
EP0240105B1 (en) A gene coding for biotin synthetase and utilization thereof
US20060088925A1 (en) Process for the intracellular over-production of streptokinase using genetically engineered strain of E.coli
Xiao A Novel Epimerase Catalyzing Multiple Isomerization of Amino Acid Residues of Ribosomal Peptide
US5340732A (en) Antiviral protein
US5766881A (en) Induction-free process for the recombinant preparation of glutarylamidase
US20040191861A1 (en) Method of protein synthesis
JPH0686681A (en) Pha intracellular degrading enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2230051

Country of ref document: CA

Ref country code: CA

Ref document number: 2230051

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: JP

Ref document number: 1997 509052

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996927785

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996927785

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1996927785

Country of ref document: EP